BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a report issued on Wednesday morning. The brokerage issued a sell rating on the medical technology company’s stock.

BIOL has been the subject of a number of other reports. Benchmark reaffirmed a “speculative buy” rating and set a $0.40 price target on shares of BIOLASE in a report on Wednesday, October 2nd. Ascendiant Capital Markets dropped their price target on BIOLASE from $3.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, September 3rd.

BIOLASE Price Performance

BIOL stock opened at $0.01 on Wednesday. The business has a fifty day moving average price of $0.02 and a 200 day moving average price of $0.07. BIOLASE has a fifty-two week low of $0.02 and a fifty-two week high of $1.94. The stock has a market capitalization of $183,738.50, a price-to-earnings ratio of 0.00 and a beta of 0.67.

Institutional Investors Weigh In On BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC boosted its holdings in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 143,537 shares of the medical technology company’s stock after acquiring an additional 131,248 shares during the period. Virtu Financial LLC owned approximately 0.43% of BIOLASE worth $27,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 8.79% of the company’s stock.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.